Hyperacusis: Loudness intolerance, fear, annoyance and pain.
Hyperacusis
annoyance
enhanced central gain
pain
stress
Journal
Hearing research
ISSN: 1878-5891
Titre abrégé: Hear Res
Pays: Netherlands
ID NLM: 7900445
Informations de publication
Date de publication:
12 2022
12 2022
Historique:
received:
29
08
2022
revised:
02
11
2022
accepted:
07
11
2022
pubmed:
18
11
2022
medline:
7
12
2022
entrez:
17
11
2022
Statut:
ppublish
Résumé
Hyperacusis is a debilitating loudness intolerance disorder that can evoke annoyance, fear and aural facial pain. Although the auditory system seems to be the "central" player, hyperacusis is linked to more than twenty non-auditory medical disorders such as Williams syndrome, autism spectrum disorder, fibromyalgia, migraine, head trauma, lupus and acoustic shock syndrome. Neural models suggest that some forms of hyperacusis may result from enhanced central gain, a process by which neural signals from a damaged cochlea are progressively amplified as activity ascends rostrally through the classical auditory pathway as well as other non-auditory regions of the brain involved in emotions, memory and stress. Imaging studies have begun to reveal the extended neural networks and patterns of functional connectivity in the brain that enrich sounds with negative attributes that can make listening unbearable and even painful. The development of animal models of hyperacusis have enabled researcher to begin to critically evaluate the biological bases of hyperacusis, identify therapies to ameliorate the symptoms and gain a better understanding of the neural mechanisms involved in loudness coding in normal and hearing impaired subjects.
Identifiants
pubmed: 36395696
pii: S0378-5955(22)00216-7
doi: 10.1016/j.heares.2022.108648
pii:
doi:
Types de publication
Journal Article
Review
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108648Subventions
Organisme : NIDCD NIH HHS
ID : R01 DC014452
Pays : United States
Organisme : NIDCD NIH HHS
ID : R01 DC014693
Pays : United States
Organisme : NIDCD NIH HHS
ID : R21 DC017813
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Competing Interest The authors declare they have no conflict or competing interests in the publication of this manuscript.